Telik (TELK) Move "Very Silly" - Feuerstein
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- Outlook Therapeutics (OTLK) halted, news pending
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
Telik (TELK) Resumes Trading, Up 73%
January 11, 2013 1:20 PM ESTTelik Inc. (NASDAQ: TELK) has resumed trading following the volatility trading halt and is now up 73% to $2.51. The company was granted orphan drug status for Telintra for myelodysplastic syndrome.... More
Telik (TELK) Surge, Halt Comes After Orphan Drug Status
January 11, 2013 1:13 PM ESTTelik Inc. (NASDAQ: TELK) halt comes after the surge in the stock following orphan drug status for Telintra for myelodysplastic syndrome... More
Telik, Inc. (TELK) trading paused for volatility
January 11, 2013 1:10 PM ESTTelik, Inc. (NASDAQ: TELK) trading paused for volatility.... More
